The quality of clinical FFP, cryoprecipitate and cryosupernatant derived from single donor apheresis procedures and random donations collected in a BAT system: Assessment of the activity states of FVIII, contact activation, microvesicle content and cytokines-Reference-Cited by-同舟云学术

The quality of clinical FFP, cryoprecipitate and cryosupernatant derived from single donor apheresis procedures and random donations collected in a BAT system: Assessment of the activity states of FVIII, contact activation, microvesicle content and cytokines

Published:1997-03 Issue:1 Volume:18 Page:115-118
ISSN:0955-3886
Container-title:Transfusion Science
language:en
Short-container-title:Transfusion Science

Author:

Seghatchian M.J.

Publisher

Elsevier BV

Subject

Hematology,Immunology

Reference7 articles.

1. Regulatory control, standardization and characterisation of clinical concentrates;Seghatchian,1989

2. Negatively charged leukocyte-filter significantly enhances Kallikrien and thrombin-like activities of platelet concentrates;Krailadsiri;Thromb Res,1996

3. Monitoring the release of glycocalicin in platelet concentrate by ELISA Blood Coag;Bessos;Fibrinol,1991

4. Cytokines levels in platelet concentrates: quantitation by bioassay and immunoassays;Wadhwa;Br J Hematol,1996

5. Quality of source plasma and optimal yields of coagulation factor concentrates;Rock,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma;Thrombosis Research;2011-07

2. Multiple Levels of Degradation Diminish Hemostatic Potential of Thawed Plasma;Journal of Trauma: Injury, Infection & Critical Care;2011-01

3. Analysis of the products of cryoprecipitation: RiCoF is deficient in cryosupernatant plasma;Transfusion and Apheresis Science;2010-10

4. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices;Transfusion and Apheresis Science;2005-08

5. What is happening? Are the current acceptance criteria for therapeutic plasma adequate?;Transfusion and Apheresis Science;2004-08